Mysterious Retro Biosciences Aims To Extend Human Lifespan By 10 Years With Cellular Anti-Aging Tech
Developing Three Approaches To Anti-Aging
Emerging from stealth mode, the Californian biotech aims to tackle aging processes looks to have some things in common with multi-billion dollar start up Altos.while also looking to legitimize the science of blood plasma transfusions.
You may also be interested in...
Provided with a record $3bn backing from investors and bringing some big names on board, Hal Barron’s new firm Altos Labs wants to “reimagine medical treatments where reversing disease for patients of any age is possible."
Several big pharma companies may be interested in buying Mirati, but could baulk at paying up to $12bn for its as-yet-unproven oncology portfolio.
The frontrunner in the new protein degrader class has shown lackluster Phase II results in breast cancer, but Arvinas hopes for success in less heavily pre-treated patients in Phase III.